Differential exhaustion on cytokine release (DECREASE) by ERY974, a novel T-cell-redirecting antibody targeting glypican-3: A new type of T-cell exhaustion

被引：0
|
作者：
Hoshino, Mayumi [1 ]
Sano, Yuji [1 ]
Kinoshita, Yasuko [1 ]
Azuma, Yumiko [1 ]
Tsunenari, Toshiaki [1 ]
Kayukawa, Yoko [1 ]
Noguchi, Mizuho [1 ]
Ishiguro, Takahiro [1 ]
Kishishita, Shohei [1 ]
Sawada, Noriaki [1 ]
Endo, Mika [1 ]
Nezu, Junichi [1 ]
机构：
[1] Chugai Pharmaceut Co Ltd, Tokyo, Japan
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-2378
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2378
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A novel CD3xPSMA bispecific antibody for efficient T cell mediated killing of prostate tumor cells with minimal cytokine release.
    Clarke, Starlynn
    Dang, Kevin
    Li, Yuping
    Sankaran, Preethi
    Duy Pham
    Balasubramani, Aarti
    Davison, Laura
    Harris, Katherine
    Jorgensen, Brett
    Schellenberger, Ute
    Trinklein, Nathan
    Ugamraj, Harshad
    Buelow, Roland
    Van Schooten, Wim
    Aldred, Shelley Force
    Buelow, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [42] Generation of a novel ROR1 x CD3 bispecific T-cell engager for better tumor killing and minimal cytokine release
    Wu, Danqing
    Gong, Shiyong
    Wu, Xuan
    Naren, Gaowa
    Dong, Liqin
    Lensky, Stephan
    Wu, Chengbin
    CANCER RESEARCH, 2024, 84 (07)
  • [43] Novel CD123xCD3 bispecific IgM antibody, IGM-2537, potently induces T-cell mediated cytotoxicity of acute myeloid leukemia cells with minimal cytokine release
    Li, Gene
    Wang, Ling
    Yakkundi, Poonam
    Hinton, Paul
    Pandya, Deepal
    Sekar, Keerthana
    Rosete, Rodine
    Ye, Zhongde
    Hanna, Nardeen
    Kotturi, Maya F.
    Bogaert, Liz
    Hong, Jiyoung
    Tsai, Christina
    Manley, Thomas
    Keyt, Bruce A.
    Sinclair, Angus M.
    Liu, Liqin
    CANCER RESEARCH, 2023, 83 (07)
  • [44] Antitumor Activity of an EpCAM/CD3-bispecific BiTE Antibody During Long-term Treatment of Mice in the Absence of T-cell Anergy and Sustained Cytokine Release
    Amann, Maria
    d'Argouges, Sandrine
    Lorenczewski, Grit
    Brischwein, Klaus
    Kischel, Roman
    Lutterbuese, Ralf
    Mangold, Susanne
    Rau, Doris
    Volkland, Joerg
    Pflanz, Stefan
    Raum, Tobias
    Muenz, Markus
    Kufer, Peter
    Schlereth, Bernd
    Baeuerle, Patrick A.
    Friedrich, Matthias
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (05) : 452 - 464
  • [45] Evaluation of Drug-Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D x CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model
    Willemin, Marie-Emilie
    Gong, Jue
    Hilder, Brandi W.
    Masterson, Tara
    Tolbert, Jaszianne
    Renaud, Thomas
    Heuck, Christoph
    Kane, Colleen
    De Zwart, Loeckie
    Girgis, Suzette
    Ma, Xuewen
    Ouellet, Daniele
    TARGETED ONCOLOGY, 2024, 19 (06) : 965 - 979
  • [46] Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine (vol 32, 10.1016/j.ymthe.2024.06.029, 2024)
    Basnet, Saru
    Van der Heijden, Mirte
    Quixabeira, Dafne C. A.
    Jirovec, Elise
    Gronberg-Vaha-Koskela, Susanna A. M.
    Clubb, James H. A.
    Kanerva, Anna
    Pakola, Santeri
    Haybout, Lyna
    Arias, Victor
    Hemminki, Otto
    Kudling, Tatiana
    Zafar, Sadia
    Cervera-Carrascon, Victor
    Santos, Joao M.
    Hemminki, Akseli
    MOLECULAR THERAPY, 2024, 32 (08) : 2800 - 2800
  • [47] TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade In Vitro and In Vivo
    Ghosh, Srimoyee
    Sharma, Geeta
    Travers, Jon
    Kumar, Sujatha
    Choi, Justin
    Jun, H. Toni
    Kehry, Marilyn
    Ramaswamy, Sridhar
    Jenkins, David
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (03) : 632 - 641
  • [48] High Avidity IgM-Based CD20xCD3 Bispecific Antibody (IGM-2323) for Enhanced T-Cell Dependent Killing with Minimal Cytokine Release
    Baliga, Ramesh
    Li, Keyu
    Manlusoc, Marigold
    Hinton, Paul
    Ng, Dean
    Tran, Madeline
    Shan, Bing
    Lu, Hai
    Saini, Avneesh
    Rahman, Sachi
    Cao, Yuan
    Saraiya, Chitra
    Peterson, Marvin
    Carroll, Steve
    Chen, Daniel
    Keyt, Bruce
    BLOOD, 2019, 134
  • [49] A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release
    Yiyang Xu
    Zhiyuan Yang
    Lucas H. Horan
    Pengbo Zhang
    Lianxing Liu
    Bryan Zimdahl
    Shon Green
    Jingwei Lu
    Javier F. Morales
    David M. Barrett
    Stephan A. Grupp
    Vivien W. Chan
    Hong Liu
    Cheng Liu
    Cell Discovery, 4
  • [50] A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release
    Xu, Yiyang
    Yang, Zhiyuan
    Horan, Lucas H.
    Zhang, Pengbo
    Liu, Lianxing
    Zimdahl, Bryan
    Green, Shon
    Lu, Jingwei
    Morales, Javier F.
    Barrett, David M.
    Grupp, Stephan A.
    Chan, Vivien W.
    Liu, Hong
    Liu, Cheng
    CELL DISCOVERY, 2018, 4
12345